Dr. Andreas Wicki is an Independent Director at Viela Bio, Inc., at Pacira Biosciences, Inc., and a Chief Executive Officer at HBM Partners AG at HBM Healthcare Investments AG.
He is on the Board of Directors at Viela Bio, Inc., HBM BioPharma India Ltd., Pacira Biosciences, Inc., HBM Biocapital Ltd., HBM BioVentures (Cayman) Ltd., HBM Healthcare Investments (Cayman) Ltd., Buchler GmbH, Harmony Biosciences LLC, MDS Pharma Services Switzerland AG and Vitaeris, Inc.
Prior to this role, from 1990-1998, he was co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG, two life sciences CRO companies which he then sold to MDS Inc., a major life sciences services and clinical research organization. After the acquisition, from 1998-2001, he was Senior Vice President of the European Analytical Operations at MDS Inc., which allowed him to become more active in analyzing, selecting, and financing biotech and med-tech companies.
Dr. Wicki holds an MSc and Ph.D. in chemistry and biochemistry from the University of Bern, Switzerland.